How to Value a Pediatric Medical Practice in 2026

Pediatric practices are unusual in the physician practice landscape. Unlike dermatology or orthopedics where private equity has driven multiples into the double digits, pediatrics remains a lower-multiple specialty. A well-run pediatric group doing $3.5M in revenue with $650K in normalized EBITDA typically sells for 3-6x EBITDA— meaning a purchase price in the $2M-$3.9M range. That's a fraction of what a comparable dermatology practice would fetch.

The reason isn't that pediatrics is a bad business. It's that the economics are structurally constrained — heavy Medicaid exposure, low RVU reimbursement, and capped per-visit revenue — and buyers discount accordingly. But that doesn't mean pediatric practice owners can't get strong exits. It means you need to understand what buyers actually pay for and position your practice around it.

Who Buys Pediatric Practices

The buyer universe for pediatrics falls into four buckets, and each values your practice differently.

Hospital systems and academic medical centers acquire pediatric practices to build feeder networks for their children's hospitals. They typically pay 3-5x EBITDA with guaranteed physician contracts, and they value panel size and geographic coverage more than standalone profitability.

Pediatric MSOs and group consolidators like Pediatric Associates (backed by Summit Partners), PM Pediatrics, and regional platforms are building scaled pediatric networks. They pay 4-7x EBITDA with equity rollover, and they're looking for practices with strong panel size, multiple locations, and physician retention potential.

Other pediatric groups— local competitors looking to absorb a retiring doctor's patient panel — typically pay based on panel value rather than EBITDA multiples. A panel of 2,500 active pediatric patients can be worth $300K-$600K on its own.

Private buyers — another pediatrician buying an owner-operator practice — pay based on SDE at roughly 1.5-2.5x. This market has gotten thinner as young physicians increasingly prefer employment over ownership.

Why Pediatric Multiples Are Lower

Three structural factors hold pediatric multiples below other specialties:

Payer mix is heavy on Medicaid and CHIP. In many markets, 30-55% of pediatric revenue comes from Medicaid, which reimburses at a fraction of commercial rates. A well-child visit billed to Blue Cross might generate $185. The same visit billed to Medicaid might generate $62. Buyers look at your payer mix and immediately calculate the revenue ceiling — you can't raise prices on Medicaid.

RVU reimbursement for pediatric E&M is low. Even commercial payers reimburse pediatric visits below other specialties because procedures are rare and visit intensity is limited. A pediatrician doing 28 visits a day generates meaningfully less revenue than a dermatologist doing the same volume.

Ancillary revenue is thin. Unlike orthopedics with imaging and injections, or dermatology with cosmetics and Mohs, pediatrics has limited ancillary opportunity. Vaccines are the main exception, and we'll get to how that affects valuation below.

Vaccine Revenue — The Quiet Value Driver

Vaccines are the most important ancillary revenue stream in pediatrics, and they're also the most commonly mismanaged. A well-run pediatric practice generates 15-25% of total revenue from vaccine administration, with margins that depend heavily on whether you're buying vaccines through the Vaccines for Children (VFC) program or through commercial channels.

VFC vaccines are federally supplied at zero cost but only reimburse the administration fee (typically $22-$28 per dose). Commercial vaccines require the practice to front the cost but reimburse both the product and an administration fee, creating a margin of $25-$85 per dose depending on the vaccine and the payer.

Buyers focus on your commercial vaccine margin because it's the real profit center. A practice with 35% commercial payer mix and an efficient vaccine workflow generates significantly more EBITDA than a nominally similar practice with 60% Medicaid. During diligence, expect buyers to pull your vaccine purchases, match them to your administration billing, and calculate per-dose margin. Any practice with vaccine waste over 3-4% or poor VFC tracking will face valuation adjustments.

Panel Size and Well-Child Visit Cadence

Pediatric practice value is fundamentally tied to panel size — the number of unique active patients under your care. The AAP-recommended well-child visit schedule drives predictable, recurring revenue: newborns through age 2 see you 8 times, age 2-6 see you annually, and school-age patients see you annually for sports physicals and checkups. Buyers model this out carefully.

The math on panel size is straightforward. Each active pediatric patient generates roughly $140-$260 per year in well-child and sick visit revenue, depending on payer mix and age distribution. A practice with 3,500 active patients and a balanced age distribution generates $490K-$910K in predictable patient revenue before you count vaccines or ancillaries.

Active panel definition matters. Buyers typically use an 18-24 month lookback to define "active" — patients seen at least once in that window. Practices that claim 6,000 patients but only have 2,800 active by that definition get marked down hard. Pull your panel data and segment it accurately before you go to market.

Age distribution matters too. A heavy concentration in the 0-3 age band signals strong new patient acquisition. A heavy concentration in the 12-17 band suggests an aging panel that will age out of pediatric care in the next 5 years, and buyers will discount accordingly.

Physician Productivity and Retention

Buyers care about two things on the physician side: how productive your doctors are, and whether they'll stay after the sale.

Productivity benchmarks in pediatrics typically show a full-time pediatrician generating $380K-$550K in annual collections at 22-30 visits per day. A doctor producing above that range is valuable and will be paid accordingly post-close. A doctor producing below that range will be subject to productivity expectations that may not align with their current work style — something to flag early with your physicians.

Retention is the bigger issue. Buyers will require 2-5 year employment agreements with non-competes as a condition of closing. If your physicians won't sign, the deal falls apart. This is a conversation you need to have with your partners well before you go to market — ideally with financial participation structured so they have skin in the game.

What Destroys Pediatric Practice Value

Unoptimized payer mix. If you have the ability to control intake and you're running 55% Medicaid in a market where you could be at 30%, you're leaving material EBITDA on the table. Some practices have a mission commitment to broad Medicaid access, and that's a real choice — but understand it's a choice that affects valuation.

Aging physicians with no succession plan. A practice where all three partners are over 62 is a practice buyers worry about. Even if the partners are willing to stay on, buyers know that 3-year employment agreements eventually expire. Build in younger physicians 5-7 years before a sale.

Poor vaccine workflow. Vaccines are margin. Waste, poor billing, mistracking VFC vs commercial inventory, and missed catch-up doses all destroy value.

Single-location dependency. Single-location practices attract fewer buyers and lower multiples than groups with 2-4 locations. Multi-site platforms signal scalability.

How to Prepare for Sale

Start 18-24 months out. Optimize your payer mix to the extent your market allows. Audit your vaccine workflow and fix any waste or billing issues. Clean up your add-backs and get reviewed financials for 3 years. Lock in physician employment structures that will transfer to a buyer. Segment your panel accurately — active patients, age distribution, and payer mix — and build a defensible panel story.

Consider whether you want to target a pediatric MSO (higher multiple, more structure, longer process) or a hospital system (lower multiple, simpler process, more security). The right answer depends on your size, geography, and retirement timeline.

The Bottom Line

Pediatric practice valuation is about stability and scale, not multiple expansion. You're unlikely to see the double-digit multiples that dermatology and orthopedics command, but a well-prepared pediatric practice can command a solid 5-6x EBITDA from the right buyer. Focus on payer mix, vaccine economics, panel quality, and physician retention — those are the levers that actually move valuation in this specialty.